Taken together, these results indicate that overexpression of murine Rnaset2 in a colon syngeneic mouse carcinoma model leads to a concerted anti-tumor immune response able to exert a tumor growth delay and rejection. The gene discussed is RNASET2; the disease is carcinoma.